NOVEL OCULAR DRUG DELIVERY DEVICES MARKET: PATENT ACTIVITY TO ACCELERATE INNOVATION

 Over 1,110 patents related to novel ocular drug delivery devices have been filed / granted in the past few years, indicating the enhanced pace of innovation in this field.

To order this detailed 180+ page report, please visit this - https://www.rootsanalysis.com/reports/novel-ocular-drug-delivery-devices-market.html

 

Over 90% of the patents related to ocular drug delivery devices have been filed / granted for implants, inserts and punctal plugs; most of the top patent assignees are industry players. Further, over the years, intellectual capital related to ocular drug delivery devices has grown at a commendable pace; majority of the high value patents have been filed / granted in the US. Words highlighted in word cloud indicate the presence of several patents for ocular implants; majority of the patents have been filed / granted for sustained release formulations for glaucoma.

To Request for sample - https://www.rootsanalysis.com/reports/novel-ocular-drug-delivery-devices-market/request-sample.html

 

With the growing prominence of sustain release therapies, ocular developers are currently focused on developing novel ocular drug delivery devices to treat various posterior ocular diseases. Given their proven benefits (which include high efficacy, target specificity and sustain release), the demand for such therapeutic modalities is on the rise. It is worth mentioning that, in the past few years, ocular drug delivery products have witnessed overwhelming success in the serious ocular conditions including glaucoma, diabetic retinopathy, diabetic macular edema and others. The global novel ocular drug delivery devices market is projected to reach USD 16 billion in 2030.

 

At present, the highest revenue generation potential is associated with inserts. It is important to note that inserts are showing better adoption in comparison to most of the marketed ocular drug delivery  implants. Further, currently, North America captures the highest share of the overall markets.

You may also be interested in the following titles:

1.     Peptides and Macrocycle Drug Discovery: Services and Platforms Market, 2020 - 2030

2.     China Biopharmaceutical Contract Manufacturing Market, 2020-2030

3.     Antibody Contract Manufacturing Market, 2020 - 2030

 

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

Contact Details

Ben Johnson

+1 (415) 800 3415

ben.johnson@rootsanalysis.com

 

Roots Analysis

Web: https://www.rootsanalysis.com/

LinkedIn: https://in.linkedin.com/company/roots-analysis

Twitter: https://twitter.com/RootsAnalysis.com

Medium: https://medium.com/@RootsAnalysis

Pinterest: https://in.pinterest.com/RootsanalysisPin/_saved/

Quora: https://rootsanalysisinsights.quora.com/

Comments

Post a Comment

Popular posts from this blog

The microbial contract biomanufacturing market is growing at a CAGR of 8.7%, claims {Roots Analysis}

    The growing pipeline of biologics that can be produced in microbial systems, such as antibody fragments and plasmid-based therapies, is anticipated to offer lucrative opportunities to service providers serving this niche, but growing market segment     London   Roots Analysis has announced the addition of the “ Microbial Contract Biomanufacturing Market, 2020-2030 ” report to its list of offerings.   Despite mammalian cell cultures being the preferred manufacturing approach for biologics, recent advances in microbial fermentation have enabled the development of versatile biomanufacturing systems, which are both robust and cost friendly. Presently, a number of service provider companies claim to offer end-to-end solutions, ranging from product development to commercial production, for microbial biologics. Given the obvious advantages of outsourcing, drug developers are likely to continue relying on contract service providers for various...
Read more

Manufacturing Market Continuous (Small Molecules and Biologics), 2020 – 2030 by Roots Analysis

  Recent advances in the manufacturing technologies have prompted pharmaceutical companies to consider shifting from the traditional multi-step, batch manufacturing processes to faster, and relatively more efficient continuous manufacturing   Roots Analysis is pleased to announce the publication of its recent study, titled, “ Manufacturing Market Continuous (Small Molecules and Biologics), 2020 – 2030 .”   The report features an extensive study of the current market landscape and future opportunities for companies with capabilities in continuous manufacturing (both innovator companies with in-house expertise and contract manufacturers). It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. In addition to other elements, the study includes: §   A detailed assessment of the overall landscape of companies with capabilities for continuous manufacturing §   Elaborate profiles of some of the key...
Read more

A relatively larger proportion of these firms are headquartered in the US, claims Roots Analysis

  Lately, drug manufacturers have started showing evident interest in modular facilities and using modularity in design approaches owing to the amplified value of smaller production facilities, which are more efficient and flexible. The increased demand for multi-product, multi-purpose, smaller batch size facilities has also prompted equipment manufacturers to revisit their product offerings.   To order this 300+ page report, which features 120+ figures and 130+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/modular-facilities-flexible-drug-manufacturing-platforms-of-the-future/178.html   The USD xx billion (by 2030) financial opportunity within the modular facilities market has been analyzed across the following segments: ·        Type of Modular Construct  §   Hybrid Skid §   Plug-and-Play §   Skid-Mounted §   Truckable §   Others §   Type of Construc...
Read more